Use of probiotics in intensive care
(2013) In Agro Food Industry Hi-Tech 24(2). p.40-44- Abstract
- The balance of intestinal microbiota, which is present in health, can be affected by severe illness and antibiotics. Pathogenic bacteria, which are usually suppressed by the commensal flora, may multiply and can cause complicating secondary infections. Administration of probiotics can help to reduce the deleterious effects of disease and antibiotics in critically ill patients: they can improve gut barrier function while reducing the load of pathogens in the gastro intestinal tract. This should reduce severe complications such as septicaemia, ventilator-associated pneumonia, and sepsis. As with all interventions there are risks involved, though these are limited when proper preparations and protocols are used. This overview of the use of... (More)
- The balance of intestinal microbiota, which is present in health, can be affected by severe illness and antibiotics. Pathogenic bacteria, which are usually suppressed by the commensal flora, may multiply and can cause complicating secondary infections. Administration of probiotics can help to reduce the deleterious effects of disease and antibiotics in critically ill patients: they can improve gut barrier function while reducing the load of pathogens in the gastro intestinal tract. This should reduce severe complications such as septicaemia, ventilator-associated pneumonia, and sepsis. As with all interventions there are risks involved, though these are limited when proper preparations and protocols are used. This overview of the use of probiotics for critically ill patients does not claim to be complete. There are several reviews on the subject (1-6) published over the last few years and most of them in 2012 (1-3, 5). (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/3932291
- author
- Klarin, Bengt LU
- organization
- publishing date
- 2013
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- probiotics, intensive care, ventilator-associated pneumonia, VAP, critical illness
- in
- Agro Food Industry Hi-Tech
- volume
- 24
- issue
- 2
- pages
- 40 - 44
- publisher
- TeknoScienze Publisher.
- external identifiers
-
- wos:000319082200011
- scopus:84878085148
- ISSN
- 1722-6996
- language
- English
- LU publication?
- yes
- id
- 32e894cf-f97c-43f6-b3ac-56213fd056d1 (old id 3932291)
- date added to LUP
- 2016-04-01 10:10:20
- date last changed
- 2022-01-25 20:31:17
@article{32e894cf-f97c-43f6-b3ac-56213fd056d1,
abstract = {{The balance of intestinal microbiota, which is present in health, can be affected by severe illness and antibiotics. Pathogenic bacteria, which are usually suppressed by the commensal flora, may multiply and can cause complicating secondary infections. Administration of probiotics can help to reduce the deleterious effects of disease and antibiotics in critically ill patients: they can improve gut barrier function while reducing the load of pathogens in the gastro intestinal tract. This should reduce severe complications such as septicaemia, ventilator-associated pneumonia, and sepsis. As with all interventions there are risks involved, though these are limited when proper preparations and protocols are used. This overview of the use of probiotics for critically ill patients does not claim to be complete. There are several reviews on the subject (1-6) published over the last few years and most of them in 2012 (1-3, 5).}},
author = {{Klarin, Bengt}},
issn = {{1722-6996}},
keywords = {{probiotics; intensive care; ventilator-associated pneumonia; VAP; critical illness}},
language = {{eng}},
number = {{2}},
pages = {{40--44}},
publisher = {{TeknoScienze Publisher.}},
series = {{Agro Food Industry Hi-Tech}},
title = {{Use of probiotics in intensive care}},
volume = {{24}},
year = {{2013}},
}